Grading of recommendations | ||||||||||
Grading for this study | NICE 2012 | VASSA 2012 | CEVF 2013 | AHA/ACC 2016 | S3 2016 | ESC 2017 | SVS 2019 | EVSM 2019 | Asian Consensus 2020 | |
For | Strong; A | Strong words (offer, measure, advice etc). | Class I | Adopted ESC model | Class I | A | Class I | Grade 1 | Class I | Adopted AHA 2016 |
Moderate; B | Less confident words, eg, ‘Consider’. | Class IIa | Class IIa | B | Class IIa | Grade 2 | Class IIa | |||
Weak; C | Class IIb | Class IIb | 0 | Class IIb | Class IIb | |||||
Ungraded: D | Consensus recommendation, insufficient evidence | Good practice statement | ||||||||
Against | No benefit; N | Class III; No benefit | Class III | Class III | ||||||
Harm; H | Do not offer. | Class III | Class III; harm |
NICE 2012; National Institute for Health and Care Excellence; Peripheral arterial disease: diagnosis and management Clinical guideline 147. VASSA 2012; Vascular Society of Southern Africa; Peripheral Arterial Disease guideline. 2012. CEVF 2013; Consensus Document on Intermittent Claudication from the Central European Vascular Forum (CEVF)—third revision (2013). AHA/ACC 2016; 2016 American Heart Association/American College of Cardiology; Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease. S3 2016; Ärzteblatt DÄG Redaktion Deutsches. The Diagnosis and Treatment of Peripheral Arterial Vascular Disease. ESC 2017; 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). SVS 2019; Joint guidelines of the Society for Vascular Surgery, European Society for Vascular Surgery, and World Federation of Vascular Societies. Global vascular guidelines on the management of chronic limb-threatening ischaemia. ESVM 2019; European Journal of Vascular Medicine. Guideline on peripheral arterial disease. 2019. Asian Consensus; Asia-Pacific Consensus Statement on the Management of Peripheral Artery Disease. 2020.